The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Valves, Glaucoma Drainage Implant, Glaucoma Tube Shunts, Stents, Others), By Surgery Method (Trabecular Meshwork Bypass, Suprachoroidal Space Implants, Subconjunctival Space Implants, Schlemm’s Canal Implants, Gonioscopy-assisted Transluminal Trabeculectomy, Endocyclophotocoagulation), By End-user ( Hospitals, Ophthalmic Clinics, Others).
The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market in 2024 signifies a transformative shift in the management of glaucoma, a leading cause of irreversible blindness. Characterized by a spectrum of innovative surgical devices and techniques, MIGS represents a paradigm shift towards safer and more effective glaucoma treatment options. As the demand for minimally invasive procedures continues to rise, the MIGS Devices Market plays a pivotal role in reshaping glaucoma management, offering ophthalmologists and patients a diverse array of cutting-edge tools to achieve optimal intraocular pressure control and preserve vision.
A prominent trend in the Minimally Invasive Glaucoma Surgery (MIGS) Devices market is the increasing integration of artificial intelligence (AI) technologies. Manufacturers are leveraging AI algorithms for real-time data analysis, enhancing the precision and efficacy of MIGS procedures. Intelligent MIGS devices offer surgeons advanced analytics, aiding in personalized treatment plans and contributing to improved patient outcomes by optimizing intraocular pressure management.
The primary driver fueling the Minimally Invasive Glaucoma Surgery (MIGS) Devices market is the escalating prevalence of glaucoma globally. As one of the leading causes of irreversible blindness, the rising incidence of glaucoma demands effective and minimally invasive treatment options. MIGS devices provide a less invasive alternative to traditional glaucoma surgeries, addressing the increasing need for efficient and safer interventions, thereby propelling market growth.
A potential opportunity in the Minimally Invasive Glaucoma Surgery (MIGS) Devices market lies in the expansion into emerging markets with a focus on glaucoma management. As awareness and healthcare infrastructure improve in developing regions, there is a growing demand for advanced glaucoma treatment options. Companies that strategically enter and cater to these emerging markets can capitalize on the unmet needs, offering innovative MIGS devices and contributing to the global efforts in preventing glaucoma-related vision loss.
By Product
By Surgery Method
By End-user
By Region
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Minimally Invasive Glaucoma Surgery (MIGS) Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Industry
4.2 Key Market Trends in Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Industry
4.3 Potential Opportunities in Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Industry
4.4 Key Challenges in Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Industry
5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Share by Company
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Outlook By Segments
7.1 Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Outlook by Segments
By Product
Valves
Glaucoma Drainage Implant
Glaucoma Tube Shunts
Stents
Others
By Surgery Method
Trabecular Meshwork Bypass
Suprachoroidal Space Implants
Subconjunctival Space Implants
Schlemm’s Canal Implants
Gonioscopy-assisted Transluminal Trabeculectomy
Endocyclophotocoagulation
By End-user
Hospitals
Ophthalmic Clinics
Others
8 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis And Outlook To 2030
8.1 Introduction to North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Markets in 2024
8.2 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size Outlook by Segments, 2021-2030
By Product
Valves
Glaucoma Drainage Implant
Glaucoma Tube Shunts
Stents
Others
By Surgery Method
Trabecular Meshwork Bypass
Suprachoroidal Space Implants
Subconjunctival Space Implants
Schlemm’s Canal Implants
Gonioscopy-assisted Transluminal Trabeculectomy
Endocyclophotocoagulation
By End-user
Hospitals
Ophthalmic Clinics
Others
9 Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis And Outlook To 2030
9.1 Introduction to Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Markets in 2024
9.2 Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook By Segments, 2021-2030
By Product
Valves
Glaucoma Drainage Implant
Glaucoma Tube Shunts
Stents
Others
By Surgery Method
Trabecular Meshwork Bypass
Suprachoroidal Space Implants
Subconjunctival Space Implants
Schlemm’s Canal Implants
Gonioscopy-assisted Transluminal Trabeculectomy
Endocyclophotocoagulation
By End-user
Hospitals
Ophthalmic Clinics
Others
10 Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Markets in 2024
10.2 Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size Outlook by Segments, 2021-2030
By Product
Valves
Glaucoma Drainage Implant
Glaucoma Tube Shunts
Stents
Others
By Surgery Method
Trabecular Meshwork Bypass
Suprachoroidal Space Implants
Subconjunctival Space Implants
Schlemm’s Canal Implants
Gonioscopy-assisted Transluminal Trabeculectomy
Endocyclophotocoagulation
By End-user
Hospitals
Ophthalmic Clinics
Others
11 South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis And Outlook To 2030
11.1 Introduction to South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Markets in 2024
11.2 South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size Outlook by Segments, 2021-2030
By Product
Valves
Glaucoma Drainage Implant
Glaucoma Tube Shunts
Stents
Others
By Surgery Method
Trabecular Meshwork Bypass
Suprachoroidal Space Implants
Subconjunctival Space Implants
Schlemm’s Canal Implants
Gonioscopy-assisted Transluminal Trabeculectomy
Endocyclophotocoagulation
By End-user
Hospitals
Ophthalmic Clinics
Others
12 Middle East And Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Markets in 2024
12.2 Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Minimally Invasive Glaucoma Surgery (MIGS) Devices Market size Outlook by Segments, 2021-2030
By Product
Valves
Glaucoma Drainage Implant
Glaucoma Tube Shunts
Stents
Others
By Surgery Method
Trabecular Meshwork Bypass
Suprachoroidal Space Implants
Subconjunctival Space Implants
Schlemm’s Canal Implants
Gonioscopy-assisted Transluminal Trabeculectomy
Endocyclophotocoagulation
By End-user
Hospitals
Ophthalmic Clinics
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AlconInc
Glaukos Corp
Johnson & Johnson Vision
AbbVie Inc (Allergan plc)
Corza Ophthalmology
Carl Zeiss Meditec AG
Katalyst Surgical
Lumenis Ltd
Ziemer Ophthalmic Systems AG
Iridex Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
By Surgery Method
By End-user
By Region
The global Minimally Invasive Glaucoma Surgery MIGS Devices Market is one of the lucrative growth markets, poised to register a 5.8% growth (CAGR) between 2024 and 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
AlconInc, Glaukos Corp, Johnson & Johnson Vision, AbbVie Inc (Allergan plc), Corza Ophthalmology, Carl Zeiss Meditec AG, Katalyst Surgical, Lumenis Ltd, Ziemer Ophthalmic Systems AG, Iridex Corp
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume